Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Identification of Potent and Selective Neuropeptide Y Y1 Receptor Agonists with Orexigenic Activity in Vivo

Deborra Mullins, Dean Kirby, Joyce Hwa, Mario Guzzi, Jean Rivier and Eric Parker
Molecular Pharmacology September 2001, 60 (3) 534-540;
Deborra Mullins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dean Kirby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Hwa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Guzzi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Rivier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Parker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Neuropeptide Y (NPY) binds to a family of G-protein coupled receptors termed Y1, Y2, Y3, Y4, Y5, and y6. The use of various receptor subtype-selective agonists and antagonists has facilitated identification of the receptor subtypes responsible for mediating many of the biological effects of NPY. For example, the potent orexigenic activity of NPY is believed to be mediated by both the Y1and Y5 receptor subtypes. Several selective Y5receptor agonists that stimulate food intake in rodents are available, but no selective Y1 receptor agonist has been reported. We have identified several NPY analogs that bind the NPY Y1receptor with high affinity and exhibit full agonist activity, measured as inhibition of forskolin-stimulated cAMP production in cells expressing the cloned NPY Y1 receptor. [d-Arg25]-NPY, [d-His26]-NPY, Des-AA10–17[Cys7,21,Pro34]-NPY, Des-AA11–18[Cys7,21,d-Lys9(Ac)]-NPY, Des-AA11–18[Cys7,21,d-Lys9(Ac),Pro34]-NPY, Des-AA11–18[Cys7,21,d-Lys9(Ac),d-His26]-NPY and Des-AA11–18[Cys7,21,d-Lys9(Ac),d-His26, Pro34]-NPY bind the NPY Y1 receptor with Kivalues of 0.9 ± 0.2, 2.0 ± 0.3, 0.2 ± 0.05, 0.7 ± 0.1, 0.2 ± 0.01, 2.2 ± 0.3, and 1.2 ± 0.3 nM, respectively, and inhibit forskolin-stimulated cAMP production with EC50 values of 0.2 ± 0.02, 0.5 ± 0.04, 0.3 ± 0.03, 0.5 ± 0.05, 0.4 ± 0.16, 5.3 ± 0.32, and 5.1 ± 0.97 nM, respectively. These peptides are highly selective for the NPY Y1 receptor relative to the NPY Y2, Y4, and Y5 receptors. [d-Arg25]-NPY, [d-His26]-NPY and Des-AA11–18[Cys7,21, d-Lys9(Ac),d-His26,Pro34]-NPY stimulate food intake dose-responsively in Long-Evans rats for at least 4 h after intracerebroventricular administration. Although the involvement of Y1 receptors in several physiological activities, such as vasoconstriction and anxiolysis, remains to be investigated, adequate tools are now available.

Footnotes

  • Abbreviations:
    NPY
    neuropeptide Y
    PP
    pancreatic polypeptide
    PYY
    peptide YY
    PVN
    paraventricular nucleus
    CHO
    Chinese hamster ovary
    HEK
    human embryonic kidney
    HBSS
    Hanks' balanced salt solution
    • Received March 6, 2001.
    • Accepted May 22, 2001.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 60 (3)
Molecular Pharmacology
Vol. 60, Issue 3
1 Sep 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Potent and Selective Neuropeptide Y Y1 Receptor Agonists with Orexigenic Activity in Vivo
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Identification of Potent and Selective Neuropeptide Y Y1 Receptor Agonists with Orexigenic Activity in Vivo

Deborra Mullins, Dean Kirby, Joyce Hwa, Mario Guzzi, Jean Rivier and Eric Parker
Molecular Pharmacology September 1, 2001, 60 (3) 534-540;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Identification of Potent and Selective Neuropeptide Y Y1 Receptor Agonists with Orexigenic Activity in Vivo

Deborra Mullins, Dean Kirby, Joyce Hwa, Mario Guzzi, Jean Rivier and Eric Parker
Molecular Pharmacology September 1, 2001, 60 (3) 534-540;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics